A nationwide analysis of population group differences in the COVID-19 epidemic in Israel, February 2020–February 2021

Summary: Background: Social inequalities affect the COVID-19 burden and vaccine uptake. The aim of this study was to explore inequalities in the incidence and mortality rate of SARS-CoV-2 infection and vaccine uptake in various sociodemographic and population group strata in Israel. Methods: We ana...

Full description

Bibliographic Details
Main Authors: Khitam Muhsen, Wasef Na'aminh, Yelena Lapidot, Sophy Goren, Yonatan Amir, Saritte Perlman, Manfred S. Green, Gabriel Chodick, Dani Cohen
Format: Article
Language:English
Published: Elsevier 2021-08-01
Series:The Lancet Regional Health. Europe
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2666776221001071
id doaj-ef5ddde56a8f4d2a9032e5548cc2722d
record_format Article
spelling doaj-ef5ddde56a8f4d2a9032e5548cc2722d2021-06-07T07:07:41ZengElsevierThe Lancet Regional Health. Europe2666-77622021-08-017100130A nationwide analysis of population group differences in the COVID-19 epidemic in Israel, February 2020–February 2021Khitam Muhsen0Wasef Na'aminh1Yelena Lapidot2Sophy Goren3Yonatan Amir4Saritte Perlman5Manfred S. Green6Gabriel Chodick7Dani Cohen8Department of Epidemiology and Preventive Medicine, School of Public Health, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, 6139001, Israel; Corresponding author at: Department of Epidemiology and Preventive Medicine, School of Public Health, Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Tel Aviv 6139001, Israel.Department of Epidemiology and Preventive Medicine, School of Public Health, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, 6139001, IsraelDepartment of Epidemiology and Preventive Medicine, School of Public Health, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, 6139001, IsraelDepartment of Epidemiology and Preventive Medicine, School of Public Health, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, 6139001, IsraelDepartment of Epidemiology and Preventive Medicine, School of Public Health, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, 6139001, IsraelDepartment of Epidemiology and Preventive Medicine, School of Public Health, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, 6139001, IsraelUniversity of Haifa, School of Public Health, Haifa, IsraelDepartment of Epidemiology and Preventive Medicine, School of Public Health, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, 6139001, Israel; Maccabi Institute for Research & Innovation, Maccabi Healthcare Services, Kaufman 4, Tel Aviv, IsraelDepartment of Epidemiology and Preventive Medicine, School of Public Health, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, 6139001, IsraelSummary: Background: Social inequalities affect the COVID-19 burden and vaccine uptake. The aim of this study was to explore inequalities in the incidence and mortality rate of SARS-CoV-2 infection and vaccine uptake in various sociodemographic and population group strata in Israel. Methods: We analysed nationwide publicly available, aggregated data on PCR-confirmed SARS-CoV-2 infections and COVID-19 deaths between March 2020 and February 2021, as well as the first three months of COVID-19 immunisation according to sociodemographics, including population group and residential socioeconomic status (SES). We computed incidence and mortality rates of COVID-19. Comparisons between towns with predominantly Arab, ultra-Orthodox Jewish (the minorities), general Jewish populations, and according to SES, were conducted using generalised linear models with negative binomial distribution. Findings: Overall, 774,030 individuals had SARS-CoV-2 infection (cumulative incidence 84•5 per 1,000 persons) and 5687 COVID-19 patients had died (mortality rate 62•8 per 100,000 persons). The highest mortality rate was found amongst the elderly. Most (>75%) individuals aged 60 years or above have been vaccinated with BNT162b2 vaccine. The risk of SARS-CoV-2 infection was higher in towns with predominantly Arab and ultra-Orthodox Jewish populations than in the general Jewish population, and in low SES communities. COVID-19 mortality rate was highest amongst Arabs. Conversely, vaccine uptake was lower amongst Arab and ultra-Orthodox Jewish populations and low SES communities. Interpretation: Ethnic and religious minorities and low SES communities experience substantial COVID-19 burden, and have lower vaccine uptake, even in a society with universal accessibility to healthcare. Quantifying these inequalities is fundamental towards reducing these gaps, which imposes a designated apportion of resources to adequately control the pandemic. Funding: No external funding was available for this study.http://www.sciencedirect.com/science/article/pii/S2666776221001071SARS-CoV-2IncidenceMortalityIsraelMinoritySocial determinants
collection DOAJ
language English
format Article
sources DOAJ
author Khitam Muhsen
Wasef Na'aminh
Yelena Lapidot
Sophy Goren
Yonatan Amir
Saritte Perlman
Manfred S. Green
Gabriel Chodick
Dani Cohen
spellingShingle Khitam Muhsen
Wasef Na'aminh
Yelena Lapidot
Sophy Goren
Yonatan Amir
Saritte Perlman
Manfred S. Green
Gabriel Chodick
Dani Cohen
A nationwide analysis of population group differences in the COVID-19 epidemic in Israel, February 2020–February 2021
The Lancet Regional Health. Europe
SARS-CoV-2
Incidence
Mortality
Israel
Minority
Social determinants
author_facet Khitam Muhsen
Wasef Na'aminh
Yelena Lapidot
Sophy Goren
Yonatan Amir
Saritte Perlman
Manfred S. Green
Gabriel Chodick
Dani Cohen
author_sort Khitam Muhsen
title A nationwide analysis of population group differences in the COVID-19 epidemic in Israel, February 2020–February 2021
title_short A nationwide analysis of population group differences in the COVID-19 epidemic in Israel, February 2020–February 2021
title_full A nationwide analysis of population group differences in the COVID-19 epidemic in Israel, February 2020–February 2021
title_fullStr A nationwide analysis of population group differences in the COVID-19 epidemic in Israel, February 2020–February 2021
title_full_unstemmed A nationwide analysis of population group differences in the COVID-19 epidemic in Israel, February 2020–February 2021
title_sort nationwide analysis of population group differences in the covid-19 epidemic in israel, february 2020–february 2021
publisher Elsevier
series The Lancet Regional Health. Europe
issn 2666-7762
publishDate 2021-08-01
description Summary: Background: Social inequalities affect the COVID-19 burden and vaccine uptake. The aim of this study was to explore inequalities in the incidence and mortality rate of SARS-CoV-2 infection and vaccine uptake in various sociodemographic and population group strata in Israel. Methods: We analysed nationwide publicly available, aggregated data on PCR-confirmed SARS-CoV-2 infections and COVID-19 deaths between March 2020 and February 2021, as well as the first three months of COVID-19 immunisation according to sociodemographics, including population group and residential socioeconomic status (SES). We computed incidence and mortality rates of COVID-19. Comparisons between towns with predominantly Arab, ultra-Orthodox Jewish (the minorities), general Jewish populations, and according to SES, were conducted using generalised linear models with negative binomial distribution. Findings: Overall, 774,030 individuals had SARS-CoV-2 infection (cumulative incidence 84•5 per 1,000 persons) and 5687 COVID-19 patients had died (mortality rate 62•8 per 100,000 persons). The highest mortality rate was found amongst the elderly. Most (>75%) individuals aged 60 years or above have been vaccinated with BNT162b2 vaccine. The risk of SARS-CoV-2 infection was higher in towns with predominantly Arab and ultra-Orthodox Jewish populations than in the general Jewish population, and in low SES communities. COVID-19 mortality rate was highest amongst Arabs. Conversely, vaccine uptake was lower amongst Arab and ultra-Orthodox Jewish populations and low SES communities. Interpretation: Ethnic and religious minorities and low SES communities experience substantial COVID-19 burden, and have lower vaccine uptake, even in a society with universal accessibility to healthcare. Quantifying these inequalities is fundamental towards reducing these gaps, which imposes a designated apportion of resources to adequately control the pandemic. Funding: No external funding was available for this study.
topic SARS-CoV-2
Incidence
Mortality
Israel
Minority
Social determinants
url http://www.sciencedirect.com/science/article/pii/S2666776221001071
work_keys_str_mv AT khitammuhsen anationwideanalysisofpopulationgroupdifferencesinthecovid19epidemicinisraelfebruary2020february2021
AT wasefnaaminh anationwideanalysisofpopulationgroupdifferencesinthecovid19epidemicinisraelfebruary2020february2021
AT yelenalapidot anationwideanalysisofpopulationgroupdifferencesinthecovid19epidemicinisraelfebruary2020february2021
AT sophygoren anationwideanalysisofpopulationgroupdifferencesinthecovid19epidemicinisraelfebruary2020february2021
AT yonatanamir anationwideanalysisofpopulationgroupdifferencesinthecovid19epidemicinisraelfebruary2020february2021
AT saritteperlman anationwideanalysisofpopulationgroupdifferencesinthecovid19epidemicinisraelfebruary2020february2021
AT manfredsgreen anationwideanalysisofpopulationgroupdifferencesinthecovid19epidemicinisraelfebruary2020february2021
AT gabrielchodick anationwideanalysisofpopulationgroupdifferencesinthecovid19epidemicinisraelfebruary2020february2021
AT danicohen anationwideanalysisofpopulationgroupdifferencesinthecovid19epidemicinisraelfebruary2020february2021
AT khitammuhsen nationwideanalysisofpopulationgroupdifferencesinthecovid19epidemicinisraelfebruary2020february2021
AT wasefnaaminh nationwideanalysisofpopulationgroupdifferencesinthecovid19epidemicinisraelfebruary2020february2021
AT yelenalapidot nationwideanalysisofpopulationgroupdifferencesinthecovid19epidemicinisraelfebruary2020february2021
AT sophygoren nationwideanalysisofpopulationgroupdifferencesinthecovid19epidemicinisraelfebruary2020february2021
AT yonatanamir nationwideanalysisofpopulationgroupdifferencesinthecovid19epidemicinisraelfebruary2020february2021
AT saritteperlman nationwideanalysisofpopulationgroupdifferencesinthecovid19epidemicinisraelfebruary2020february2021
AT manfredsgreen nationwideanalysisofpopulationgroupdifferencesinthecovid19epidemicinisraelfebruary2020february2021
AT gabrielchodick nationwideanalysisofpopulationgroupdifferencesinthecovid19epidemicinisraelfebruary2020february2021
AT danicohen nationwideanalysisofpopulationgroupdifferencesinthecovid19epidemicinisraelfebruary2020february2021
_version_ 1721391547637825536